Skip to main content
. 2016 Apr;22(4):10.18553/jmcp.2016.22.4.316. doi: 10.18553/jmcp.2016.22.4.316

TABLE 4.

Differences in the Occurrence of COPD Exacerbations 6 Months Preand Postconversion from Fluticasone/Salmeterol to Mometasone/Formoterol

Mometasone/formoterola
Exacerbation No exacerbation Tot al
Fluticasone/salmeterolb Exacerbation, n 80 98 178
No exacerbation, n 69 274 343
Total 149 372 521

Note: P = 0.030.

a Postconversion.

b Preconversion.

COPD = chronic obstructive pulmonary disease